Viz.ai Launches AI-Powered Viz Cardio Suite

November 8, 2022—Viz.ai announced the launch of a full cardiology suite to speed and improve patient access to innovative cardiovascular treatments. Viz Cardio Suite leverages artificial intelligence (AI)–powered disease detection, workflow optimization, and care team coordination to provide efficiencies in the delivery of cardiovascular care.

Viz.ai stated that the Cardio Suite streamlines care pathways by improving patient identification, developing disease-specific workflows, and connecting patients to the right provider in their medical journey.

“Tools like the Viz Cardio Suite will identify patients with targeted cardiovascular diseases and ensure the right clinician is alerted and involved in the patient’s care at the right time with the right therapy,” commented Kenneth Rosenfield, MD, in the company’s press release. “Furthermore, using this latest technology will help bridge neurology and cardiology care teams to advance the heart-brain connection and improve how we treat stroke as well as structural heart disease, atrial fibrillation, and other debilitating cardiac diseases.” Dr. Rosenfield is an interventional cardiologist and Section Head of Vascular Medicine and Intervention at Massachusetts General Hospital in Boston, Massachusetts.

Viz.ai introduced the Cardio Suite at the American Heart Association Scientific Sessions 2022 held November 5-7 in Chicago, Illinois.